SAN DIEGO–(BUSINESS WIRE)–Sep. 20, 2018– Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
Heart failure patients with mitral regurgitation benefit from minimally invasive procedure
A multicenter clinical trial has found that a minimally invasive
Study shows surprise low-level ozone impact on asthma patients
A new study led by UNC School of Medicine researchers
Cardiac monitoring needed for high-risk breast cancer patients
(HealthDay)—Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or
Caffeine prolongs the life of kidney patients
Increased consumption of caffeine may help reduce the risk of
Fingolimod cuts multiple sclerosis relapses in pediatric patients
(HealthDay)—Among pediatric patients with relapsing multiple sclerosis, fingolimod is associated
Supreme court ruling to the dentist Botch: patients have to pay no fee
The Federal court of justice strengthens the rights of patients
A new spinal cord injury treatment is getting patients back on their feet
Matt Wetschler was bodysurfing at Ocean Beach in San Francisco
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
THOUSAND OAKS, Calif., Sept. 6, 2018 /PRNewswire/ — Amgen (NASDAQ:
Here's Why Doctors Prescribe Antidepressants to Patients Who Aren't Depressed
Many prescription medications have "off-label" uses, and antidepressants are no